Placebo pills, lotions or potions and the natural progression of patterned hair loss in males: Another step away from "trichoquackery"?

European Journal of Dermatology

Volumn 18, Issue 4, 2008, Pages 373-375

  Van Neste, Dominique ^a  

^a Skin Study Center   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; EDITORIAL; HAIR LOSS; HUMAN; LOTION; MALE; PILL; PLACEBO EFFECT; QUACKERY; SCALP HAIR;

ALOPECIA; DISEASE PROGRESSION; DOSAGE FORMS; HUMANS; MALE; PHOTOGRAPHY; PLACEBO EFFECT; PLACEBOS;

EID: 47749091223     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0430     Document Type: Editorial

References (17)

1. Kaufman K, Girman CJ, Round EM, Johnson-Levonas AO, Shah AK, Rotonda J. Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients. Eur J Dermatol 2008; 18(4): 400-6.
2. Kaufman K, Rotonda J, Shah AK, Meehan AG. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss). Eur J Dermatol 2008; 18(4): 407-11.
3. Bircher A, de Boer EM, Agner T, Wahlberg JE, Serup J. Guidelines for measurement of cutaneous blood flow by laser Doppler flowmetry. Contact Dermatitis 1994; 30: 65-72.
4. Van Neste D. Folliculogram demonstrates more anagen hair roots in male androgenetic alopecia after one year treatment with finasteride 1mg/d. In: Van Neste D, Blume-Peytavi U, Grimalt R, Messenger A, eds. Hair Science and Technology. Tournai-Belgium: Skinter-face sprl, 2003: 311-6.
5. Van Neste D. Natural scalp hair regression in preclinical stages of male androgenetic alopecia and its reversal by finasteride. Skin Pharmacol Physiol 2006; 19: 168-76.
6. Van Neste D, De Brouwer B, De Coster W. The phorotrichogram: analysis of some technical factors of variation. Skin Pharmacol 1994; 7: 67-72.
7. Olsen EA. Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss. J Am Acad Dermatol 2003; 48: 253-62.
8. Messenger AG, Sinclair R. Follicular miniaturization in female pattern hair loss: clinicopathological correlations. Br J Dermatol 2006; 155: 926-30.
9. Van Neste D, Trüeb R. Critical study of hair growth analysis with computer-assisted methods. J Eur Acad Dermatol Venerol 2006; 20: 578-85.
10. Rushton H, James KC, Mortimer CH. The unit area trichogram in the assessment of androgen-dependent alopecia. Br J Dermatol 1983; 109: 429-37.
11. Rushton DH, Ramsay ID, Norris MJ, Gilkes JJ. Natural progression of male pattern baldness in young men. Clin Exp Dermatol 1991; 16: 188-92.
12. Rushton H. Comparative efficacy of oral finasteride and topical 2% minoxidil in male pattern baldness. In: Van Neste D, Blume-Peytavi U, Messenger A, Grimalt R, eds. Hair Science and Technology. Tournai-Belgium: Skinterface sprl, 2003: 317-29.
13. Van Neste DJ. Hair growth evaluation in clinical dermatology. Dermatology 1993; 187: 233-4.
14. Milner Y, Sudnik J, Filippi M, Kizoulis M, Kashgarian M, Stenn K. Exogen, shedding phase of the hair growth cycle: characterization of a mouse model. J Invest Dermatol 2002; 119: 639-44.
15. Van Neste D, Leroy T, Conil S. Exogen hair characterization in human scalp. Skin Res Technol 2007; 13: 436-43.
16. Schmitt Daniel, Noly Valerie. L'homme et sa peau. Lyon (France): ARPPAM - Edition, Museum de Lyon, 1996; 1-111.
17. Leroy T, Van Neste D. Contrast enhanced phorotrichogram pinpoints scalp hair changes in androgen sensitive areas of male androgenetic alopecia. Skin Research and Technology 2002; 8: 106-11.